Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Wiegand: Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in.... (0.14 sec) 

Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with …

- duanesolution.com
TW Wiegand, AH Rogers, F McCabe, E … - British Journal of Ophthalmology, 2009 - bjo.bmj.com
Results: With a mean follow-up of 19 months (range 10 to 28 months), the best
corrected visual acuity improved by three or more lines in four eyes (44.4%),
remained within two lines of baseline in four eyes (44.4%) and decreased by ...
Cited by 5 - Related articles - All 4 versions

Long-term control of choroidal neovascularisation secondary to angioid streaks treated with …

- prsjournal.com
P Neri, S Salvolini, C Mariotti, L Mercanti, S … - British Journal of Ophthalmology, 2009 - bjo.bmj.com
Methods: Patients with unilateral active CNV associated with AS were enrolled.
Exclusion criteria were previous treatment for CNV and comorbidity.
Postoperative visual acuity was defined as a gain or loss of two or more ...
Cited by 4 - Related articles - All 4 versions

Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: A …


MC Donati, G Virgili, A Bini, F Giansanti, E … - Ophthalmologica, 2009 - content.karger.com
Background: Intravitreal (IV) bevacizumab (Avastin®, Roche), initially used for
the off-label treatment of neovascular age-related macular degeneration (AMD),
has extended itself to treat various ocular pathologies such as choroidal ...
Cited by 2 - Related articles - All 4 versions

Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: …


JM Monés, L Amselem, A Serrano, M Garcia, … - Eye, 2009 - nature.com
There were 23 eyes of 23 patients, and the mean age was 51.08 (SD=17.40) years.
One patient was lost during the follow-up. At the 12-month follow-up, the mean
VA improved by 9.53 letters (P<0.05). In all, 69% of patients increased at ...
Cited by 2 - Related articles - All 3 versions

Intravitreal Bevacizumab (Avastin) Treatment of


A Streaks - bjo.bmj.com
Page 1. doi: 10.1136/bjo.2008.143461 published online October 29, 2008 Br J
Ophthalmol Torsten W Wiegand, Adam H Rogers, Frank McCabe, et al. ...
Related articles

Photodynamic therapy for angioid streaks


AC Browning, WM Amoaku, AK Chung, F … - Ophthalmology, 2007 - Elsevier
The patient demographics and baseline characteristics have been reported
previously. Sixteen eyes with subfoveal choroidal neovascularization and 7 with
juxtafoveal lesions at baseline were recruited. Twenty-two eyes of 21 ...
Cited by 4 - Related articles - All 7 versions

Intravitreal bevacizumab for the management of choroidal neovascularization in …


P Bhatnagar, KB Freund, RF Spaide, JM … - Retina, 2007 - pdfs.journals.lww.com
6 gene (ABCC6).2–5 The ophthalmic manifestations of PXE variably include
angioid streaks, reticular mac- ular dystrophy, peau d'orange fundus changes,
optic nerve drusen, and comet-like peripheral lesions.1,6 An- gioid ...
Cited by 18 - Related articles - BL Direct - All 3 versions

Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization


S Mandal, S Garg, P Venkatesh, C Mithal, R … - Archives of Ophthalmology, 2007 - archopht.highwire.org
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ...
Cited by 11 - Related articles - BL Direct - All 3 versions

Long-term Results of Intravitreal Bevacizumab Injection for Choroidal Neovascularization …


M Sawa, F Gomi, M Tsujikawa, H Sakaguchi, … - American Journal of Ophthalmology, 2009 - Elsevier
The mean follow-up was 19 months (range, 12 to 24 months). The mean number of
injections for primary CNV was 4.5 (range, 1 to 9). The mean preoperative BCVA
(decimal equivalent) was 0.39 (range, 0.08 to 1.5) and 0.47 (range, 0.06 to ...
Related articles - All 12 versions

Intravitreal bevacizumab for choroidal neovascularisation secondary to causes other than …


B Gupta, M Elagouz, S Sivaprasad - Eye, 2009 - nature.com
Choroidal neovascularisation (CNV) is characterised by new blood vessel growth
under the retina that usually results in significant visual impairment when the
fovea is involved. Though CNV is more commonly associated with age-related ...
Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google